21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency

This publication has 30 references indexed in Scilit:

• Cases of Congenital Adrenal Hyperplasia Missed by Newborn Screening in Minnesota
  JAMA, 2012
• Use of Steroid Profiling by UPLC-MS/MS as a Second Tier Test in Newborn Screening for Congenital Adrenal Hyperplasia: The Utah Experience
  Pediatric Research, 2009
• Newborn Screening for Congenital Adrenal Hyperplasia: Additional Steroid Profile using Liquid Chromatography-Tandem Mass Spectrometry
  The Journal of Clinical Endocrinology & Metabolism, 2007
• Cutoff Levels of 17-α-Hydroxyprogesterone in Neonatal Screening for Congenital Adrenal Hyperplasia Should Be Based on Gestational Age Rather Than on Birth Weight
  The Journal of Clinical Endocrinology & Metabolism, 2005
• Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass Spectrometry
  Clinical Chemistry, 2004
• Screening for Congenital Adrenal Hyperplasia: Adjustment of 17-Hydroxyprogesterone Cut-Off Values to Both Age and Birth Weight Markedly Improves the Predictive Value
  The Journal of Clinical Endocrinology & Metabolism, 2003
• Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
  Pediatrics, 1998
• Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels
  The Journal of Pediatrics, 1997
• Newborn Screening for Congenital Adrenal Hyperplasia with Special Reference to Screening in Alaska^a
  Annals of the New York Academy of Sciences, 1985
• Psychological Reactions in 102 Families with a Newborn Who Has a Falsely Positive Screening Test for Congenital Hypothyroidism
  Acta Paediatrica, 1983